Distribution of extended spectrum β-lactamases-codifying genes in Klebsiella pneumoniae isolates from hospitals of Bogota, D.C., Colombia;Distribución de genes codificadores de β-lactamasas de espectro extendido en aislamientos de Klebsiella pneumoniae de hospitales de Bogotá, D.C, Colombia

Biomedica

Volumn 31, Issue 1, 2011, Pages 15-20

  Pulido, Ingrid Yamile ^a   Mantilla, José Ramón ^a   Valenzuela, Emilia María ^a   Reguero, María Teresa ^a   Gonzalez, Elsa Beatriz ^a  

^a UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

Author keywords

Bacterial; Beta lactamases; Colombia; DNA; Drug resistance; Klebsiella pneumoniae; Molecular epidemiology; Sequence analysis

Indexed keywords

BACTERIA (MICROORGANISMS); ENTEROBACTERIACEAE; KLEBSIELLA PNEUMONIAE;

EID: 84856181092     PISSN: 01204157     EISSN: None     Source Type: Journal    
DOI: 10.7705/biomedica.v31i1.331     Document Type: Article

References (31)

1. Martínez JL, Baquero F. Interactions among strategies associated with bacterial infection: Pathogenicity, epidemicity and antibiotic resistance. Clin Microbiol Rev. 2002;4:647-79.
2. Bonnet R. Growing group of extended-spectrum β-lactamases: The CTX-M enzymes. Antimicrob Agents Chemother. 2004;48:1-14.
3. Pagani L, Delĺamico E, Migliavacca R, D'Andrea MM, Giacobone E, Amicosante G, et al. Multiple CTX-M-type extended-spectrum β-lactamases in nosocomial isolates of Enterobacteriaceae from a hospital in Northern Italy. J Clin Microbiol. 2003;41:4264-9.
4. Van't veen A, van der Zee A, Nelson J, Speelberg B, Kluytmans JA, Buiting AG. Outbreak of infection with a multiresistant Klebsiella pneumoniae strain associated with contaminated roll boards in operating rooms. J Clin Microbiol. 2005;43:4961-7.
5. Ben-Hamouda T, Foulon T, Ben-Cheikn-Masmoudi A, Fendri C, Belhadj O, Ben Mahrez K. Molecular epidemiology of an outbreak of multiresistant Klebsiella pneumoniae in a Tunisian neonatal ward. J Med Microbiol. 2003;52:427-33.
6. Podschun R, Ullmann U. Klebsiella spp. as nosocomial pathogens: Epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev. 1998;11:589-603.
7. Winokur PL, Canton R, Casellas JM, Legakis N. Variations in the prevalence of strains expressing an extended-spectrum β-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region. Clin Infect Dis. 2001;32(Suppl. 2):S94-103.
8. The Colombian Resistance Antimicrobial Group, Jones RN, Salazar JC, Pfaller MA, Doern GV. Multicenter evaluation of antimicrobial resistance to six broad-spectrum β-lactams in Colombia using the Etest method. Diagn Microbiol Infect Dis. 1997;29:265-72.
9. The Colombian Antimicrobial Resistance Study Group, Pfaller MA, Jones RN, Doern GV, Salazar JC. Multicenter evaluation of antimicrobial resistance to six broad-spectrum beta-lactams in Colombia: Comparison of data from 1997 and 1998 using the Etest method. Diagn Microbiol Infect Dis. 1999;35:235-41.
10. Valenzuela E, Mantilla J, Reguero M, González E, Pulido I, Llerena I, et al. Detection of CTX-M-1, CTX-M-15, and CTX-M-2 in clinical isolates of Enterobacteriaceae in Bogotá, Colombia. J Clin Microbiol. 2005;44:1919-20.
11. Espinal P, Mantilla J, Saavedra C, Leal A, Alpuche C, Valenzuela E. Epidemiología molecular de la infección nosocomial por Klebsiella pneumoniae productora de beta-lactamasas de espectro extendido. Biomédica. 2004;24:252-61.
12. Villegas M, Correa A, Pérez F, Miranda MC, Zuluaga T, Quinn JP, et al. Prevalence and characterization of extended-spectrum β-lactamases in Klebsiella pneumoniae and Escherichia coli isolates from Colombian hospitals. Diagn Microbiol Infect Dis. 2004;49:217-22.
13. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibillity testing. Sixteenth Informational supplement. CLSI document M-100-S16 (ISBN 1-56238-588-7). Wayne: Clinical and Laboratory Standards Institute; 2006.
14. Jarlier V, Nicolas MH, Fournier G, Philippon A. Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactams agents in Enterobacteriaceae: Hospital prevalence and susceptibility patterns. Rev Infect Dis. 1988;10:867-78.
15. Cao V, Lambert T, Quynh Nhu D, Loan HK, Hoang N, Arlet G, et al. Distribution of extended-spectrun β-lactamases in clinical isolates of Enterobacteriaceae in Vietnam. Antimicrob Agents Chemother. 2002;46:3739-43.
16. Neuwirth C, Madec S, Siebor E. TEM-89 β-lactamase produced by Proteus mirabilis clinical isolate: New complex mutant (CMT 3) with mutations in both TEM-59 (IRT-17) and TEM-3. Antimicrob Agents Chemother. 2001;45:3591-4.
17. Bonnet R, Dutour J, Sampaio M, Chanal C, Sirot D, Labia R, et al. Novel cefotaxime (CTX-M-16) with increase catalytic efficiency due to substitution Asp-240-Gli. Antimicrob Agents Chemother. 2001;45:2269-75.
18. Nagano N, Shibata N, Saitou Y, Nagano Y, Arakawa Y. Nosocomial outbreak infections by Proteus mirabilis that produces extended-spectrum CTX-M-2 type β-lactamase. J Clin Microbiol. 2003;41:5530-6.
19. Chanawong A, M'Zali FH, Heritage J, Xiong J, Hawkey PM. Three cefotaximases, CTX-M-9, CTX-M-13, and CTX-M-14, among Enterobacteriaceae in the People's Republic of China. Antimicrob Agents Chemother. 2002;46:630-7.
20. Shibata N, Kurokawa H, Doi Y, Yagi T, Yamane K, Wachino J, et al. PCR classification of CTX-M-type β-lactamase genes identified in clinically isolated gram-negative bacilli in Japan. Antimicrob Agents Chemother. 2006;50:791-5.
21. Bouza E, San Juan R, Muñoz P, Voss A, Kluytmans J. A European perspective on nosocomial urinary tract infections II. Report on incidence, clinical characteristics and outcome (ESGNI-004study). Clin Microbiol Infect. 2001;7:532-42.
22. Kil K, Darouiche RO, Hull RA, Mansouri MD, Musher DM. Identification of a Klebsiella pneumoniae strain associated with nosocomial urinary tract infection. J Clin Microbiol. 1997;35:2370-4.
23. Suljagic V, Cobeljic M, Jankovic S, Mirovic V, Markovic-Denic L, Romic P, et al. Nosocomial bloodstream infections in ICU and non-ICU patients. Am J Infect Control. 2005;33:333-40.
24. Biedenbach DJ, Moet GJ, Jones RN. Ocurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997- 2002). Diag Microbiol Infect Dis. 2004;50:59-69.
25. Kariuki S, Corkill J, Revathi G, Musoke R, Hart CA. Molecular characterization of a novel plasmid-encoded-cefotaximase (CTX-M-12) found in clinical Klebsiella pneumoniae isolates from Kenya, Antimicrob Agents Chemother. 2001;45:2141-3.
26. Villegas MV, Correa A, Pérez F, Zuluaga T, Radice M, Gutkind G, et al. CTX-M-12 β-lactamase in a Klebsiella pneumoniae isolate in Colombia. Antimicrob Agents Chemother. 2004;48:629-31.
27. Corkill JE, Cuevas LE, Gurgel RQ, Greensill J, Hart CA. SHV-27, a novel cefotaxime-hydrolyzing ß-lactamase, identified in Klebsiella pneumoniae isolates from a Brazilian hospital. J Antimicrob Chemother. 2001;47:463-5.
28. Segatore B, Setacci D, Perilli M, Franchino L, Franceschini N, Agnifili A, et al. Antimicrobial susceptibility of clinical isolates of Enterobacteriaceae producing complex β-lactamase patterns including extended-spectrum enzymes. Int J Antimicrob Agents. 2004;23:480-6.
29. Xiong Z, Zhu D, Wang F, Zhang Y, Okamoto R, Inoue M. A Klebsiella pneumoniae producing three kinds of class A β-lactamases encoded by one single plasmid isolated from a patient in Huashan Hospital, Shanghai, China. Int J Antimicrob Agents. 2004;23:262-7.
30. Bradford PA. Extended-spectrum β-lactamases in the 21st century: Characterization, epidemiology and detection of this important resistance threat. Clin Microbiol Rev. 2001;14:933-51.
31. Siu LK, Lu P, Hsueh P, Lin FM, Chang S, Luh K, et al. Bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a pediatric oncology ward: Clinical features and identification of different plasmids carrying both SHV-5 and TEM-1 genes. J Clin Microbiol. 1999;37:4020-7.